This intricate interplay between neurons and glioma cells, mediated by paracrine signals such as BDNF, NLGN3, and IGF‐1, underscores the complexity of the TME in brain tumors and highlights potential therapeutic targets for future interventions. The gene discussed is NLGN3; the disease is glioma.